Conclusion L-carnitine and acetyl-L-carnitine show potential as supplementary treatments in cancer primarily by helping manage side effects during and after conventional treatment
doi: 10.3390/foods13213507, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 184
Additional information Supplementary Information accompanies this paper on European Journal of Clinical Nutrition website Supplementary information Rights and permissions About this article Cite this article Sinha, R., Sinha, I., Calcagnotto, A
The general approach is to cycle it (8-12 weeks on, 4-6 weeks off) and work with a healthcare provider who can monitor relevant biomarkers
It helps reduce melanin production in the skin, leading to a lighter and more uniform complexion
Patients should review safety information and discuss risks with a qualified medical provider